Unique Benefits of Nanotechnology to Drug Delivery and Diagnostics View Full Text


Ontology type: schema:Chapter     


Chapter Info

DATE

2010-10-19

AUTHORS

Scott E. McNeil

ABSTRACT

Nanotechnology offers many potential benefits to medical research by making pharmaceuticals more efficacious and by decreasing their adverse side-effects. Preclinical characterization of nanoparticles intended for medical applications is complicated--due to the variety of materials used, their unique surface properties and multifunctional nature. This chapter serves as an introduction to the volume, giving a broad overview of applications of nanotechnology to medicine, and describes some of the beneficial aspects of nanotechnology-based drug delivery. We define nanotechnology and provide brief descriptions of the major classes of nanomaterials used for medical applications. The following two chapters discuss scientific and regulatory hurdles involved in the use of nanotechnology in medicine. The remaining bulk of the volume provides the reader with protocols that have been tested against clinically relevant nanoparticles and describes some of the nuances of nanoparticle types and necessary controls. More... »

PAGES

3-8

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/978-1-60327-198-1_1

DOI

http://dx.doi.org/10.1007/978-1-60327-198-1_1

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1034612500

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/21116949


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/0306", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Physical Chemistry (incl. Structural)", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/03", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Chemical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Animals", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Delivery Systems", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug-Related Side Effects and Adverse Reactions", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Nanomedicine", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Nanoparticles", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Nanostructures", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Nanotechnology", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Pharmaceutical Preparations", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Surface Properties", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "name": [
            "Nanotechnology Characterization Laboratory, Advanced Technology Program, SAIC \u2013 Frederick, Inc., National Cancer Institute at Frederick, Frederick, MD, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "McNeil", 
        "givenName": "Scott E.", 
        "id": "sg:person.01066372523.29", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01066372523.29"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/nrd1033", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000722784", 
          "https://doi.org/10.1038/nrd1033"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nrd1033", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000722784", 
          "https://doi.org/10.1038/nrd1033"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1073/pnas.93.24.14164", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001856115"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.addr.2005.09.014", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003846396"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/1078-0432.ccr-05-1634", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007182456"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/annonc/mdl104", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035014334"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1359-6446(03)02903-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038206642"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1080/10717540490433895", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038778560"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0168-3659(99)00248-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044151490"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/0-306-47932-x_2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047588034", 
          "https://doi.org/10.1007/0-306-47932-x_2"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1517/14712598.4.8.1213", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1067589512"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2010-10-19", 
    "datePublishedReg": "2010-10-19", 
    "description": "Nanotechnology offers many potential benefits to medical research by making pharmaceuticals more efficacious and by decreasing their adverse side-effects. Preclinical characterization of nanoparticles intended for medical applications is complicated--due to the variety of materials used, their unique surface properties and multifunctional nature. This chapter serves as an introduction to the volume, giving a broad overview of applications of nanotechnology to medicine, and describes some of the beneficial aspects of nanotechnology-based drug delivery. We define nanotechnology and provide brief descriptions of the major classes of nanomaterials used for medical applications. The following two chapters discuss scientific and regulatory hurdles involved in the use of nanotechnology in medicine. The remaining bulk of the volume provides the reader with protocols that have been tested against clinically relevant nanoparticles and describes some of the nuances of nanoparticle types and necessary controls.", 
    "editor": [
      {
        "familyName": "McNeil", 
        "givenName": "Scott E.", 
        "type": "Person"
      }
    ], 
    "genre": "chapter", 
    "id": "sg:pub.10.1007/978-1-60327-198-1_1", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.5246872", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": {
      "isbn": [
        "978-1-60327-197-4", 
        "978-1-60327-198-1"
      ], 
      "name": "Characterization of Nanoparticles Intended for Drug Delivery", 
      "type": "Book"
    }, 
    "name": "Unique Benefits of Nanotechnology to Drug Delivery and Diagnostics", 
    "pagination": "3-8", 
    "productId": [
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "21116949"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1034612500"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/978-1-60327-198-1_1"
        ]
      }, 
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "a4e1bc1a2cf1f875c0fac7dc71f69fa4869461d93ba5144422ae1498ab376958"
        ]
      }
    ], 
    "publisher": {
      "location": "Totowa, NJ", 
      "name": "Humana Press", 
      "type": "Organisation"
    }, 
    "sameAs": [
      "https://doi.org/10.1007/978-1-60327-198-1_1", 
      "https://app.dimensions.ai/details/publication/pub.1034612500"
    ], 
    "sdDataset": "chapters", 
    "sdDatePublished": "2019-04-16T08:32", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000364_0000000364/records_72859_00000000.jsonl", 
    "type": "Chapter", 
    "url": "https://link.springer.com/10.1007%2F978-1-60327-198-1_1"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/978-1-60327-198-1_1'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/978-1-60327-198-1_1'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/978-1-60327-198-1_1'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/978-1-60327-198-1_1'


 

This table displays all metadata directly associated to this object as RDF triples.

142 TRIPLES      23 PREDICATES      47 URIs      30 LITERALS      19 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/978-1-60327-198-1_1 schema:about N0a951a8a241e4a2492fc3e716cceabd1
2 N1bf18497705c4ab5835293648a3e4bc9
3 N3351d315795e4672950b0685d4311520
4 N45fbcfb8aed04913b4f2468d4c8cdd6a
5 N587ff922e2624318897535028199731d
6 N726ad3be7ca246fd9fb029a305cc4087
7 N77404aa9542f497bb8859e72d7e75cff
8 N7ad217b2bce44b89811c4ee30cfa5673
9 N96b1612ad41c414ca2a59b94bfd57eac
10 Nf73d3c9d75574d9c953f9ba9f16b8d6d
11 anzsrc-for:03
12 anzsrc-for:0306
13 schema:author N4addd2357bfe40ffad01169400c2864b
14 schema:citation sg:pub.10.1007/0-306-47932-x_2
15 sg:pub.10.1038/nrd1033
16 https://doi.org/10.1016/j.addr.2005.09.014
17 https://doi.org/10.1016/s0168-3659(99)00248-5
18 https://doi.org/10.1016/s1359-6446(03)02903-9
19 https://doi.org/10.1073/pnas.93.24.14164
20 https://doi.org/10.1080/10717540490433895
21 https://doi.org/10.1093/annonc/mdl104
22 https://doi.org/10.1158/1078-0432.ccr-05-1634
23 https://doi.org/10.1517/14712598.4.8.1213
24 schema:datePublished 2010-10-19
25 schema:datePublishedReg 2010-10-19
26 schema:description Nanotechnology offers many potential benefits to medical research by making pharmaceuticals more efficacious and by decreasing their adverse side-effects. Preclinical characterization of nanoparticles intended for medical applications is complicated--due to the variety of materials used, their unique surface properties and multifunctional nature. This chapter serves as an introduction to the volume, giving a broad overview of applications of nanotechnology to medicine, and describes some of the beneficial aspects of nanotechnology-based drug delivery. We define nanotechnology and provide brief descriptions of the major classes of nanomaterials used for medical applications. The following two chapters discuss scientific and regulatory hurdles involved in the use of nanotechnology in medicine. The remaining bulk of the volume provides the reader with protocols that have been tested against clinically relevant nanoparticles and describes some of the nuances of nanoparticle types and necessary controls.
27 schema:editor N4d6f8b24b051410780c8784d55e11cd5
28 schema:genre chapter
29 schema:inLanguage en
30 schema:isAccessibleForFree false
31 schema:isPartOf N93719bc9bdf74e2a923f74bb12efcd4c
32 schema:name Unique Benefits of Nanotechnology to Drug Delivery and Diagnostics
33 schema:pagination 3-8
34 schema:productId N536f0b643bc5408f8d14a17bd0703f98
35 Nc99c426cc50d4a1b973e0751033b6489
36 Ncdb343dbe4fb41b891f6651377e159fd
37 Nd7ca21cc8b9d48889ba9c3b5e4de0570
38 schema:publisher Neea06bb06c8540f28524d61606bde706
39 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034612500
40 https://doi.org/10.1007/978-1-60327-198-1_1
41 schema:sdDatePublished 2019-04-16T08:32
42 schema:sdLicense https://scigraph.springernature.com/explorer/license/
43 schema:sdPublisher N738ad361f1df448d9af6a7fd3eb9dcf5
44 schema:url https://link.springer.com/10.1007%2F978-1-60327-198-1_1
45 sgo:license sg:explorer/license/
46 sgo:sdDataset chapters
47 rdf:type schema:Chapter
48 N0a951a8a241e4a2492fc3e716cceabd1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
49 schema:name Pharmaceutical Preparations
50 rdf:type schema:DefinedTerm
51 N1bf18497705c4ab5835293648a3e4bc9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
52 schema:name Animals
53 rdf:type schema:DefinedTerm
54 N3351d315795e4672950b0685d4311520 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
55 schema:name Nanotechnology
56 rdf:type schema:DefinedTerm
57 N45fbcfb8aed04913b4f2468d4c8cdd6a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
58 schema:name Drug-Related Side Effects and Adverse Reactions
59 rdf:type schema:DefinedTerm
60 N4addd2357bfe40ffad01169400c2864b rdf:first sg:person.01066372523.29
61 rdf:rest rdf:nil
62 N4d6f8b24b051410780c8784d55e11cd5 rdf:first N896e69eb77b2422c9c8367d90e7795a8
63 rdf:rest rdf:nil
64 N5160a2b2159747bcb1f2d51deebb607d schema:name Nanotechnology Characterization Laboratory, Advanced Technology Program, SAIC – Frederick, Inc., National Cancer Institute at Frederick, Frederick, MD, USA
65 rdf:type schema:Organization
66 N536f0b643bc5408f8d14a17bd0703f98 schema:name readcube_id
67 schema:value a4e1bc1a2cf1f875c0fac7dc71f69fa4869461d93ba5144422ae1498ab376958
68 rdf:type schema:PropertyValue
69 N587ff922e2624318897535028199731d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
70 schema:name Nanostructures
71 rdf:type schema:DefinedTerm
72 N726ad3be7ca246fd9fb029a305cc4087 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
73 schema:name Nanomedicine
74 rdf:type schema:DefinedTerm
75 N738ad361f1df448d9af6a7fd3eb9dcf5 schema:name Springer Nature - SN SciGraph project
76 rdf:type schema:Organization
77 N77404aa9542f497bb8859e72d7e75cff schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
78 schema:name Nanoparticles
79 rdf:type schema:DefinedTerm
80 N7ad217b2bce44b89811c4ee30cfa5673 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
81 schema:name Surface Properties
82 rdf:type schema:DefinedTerm
83 N896e69eb77b2422c9c8367d90e7795a8 schema:familyName McNeil
84 schema:givenName Scott E.
85 rdf:type schema:Person
86 N93719bc9bdf74e2a923f74bb12efcd4c schema:isbn 978-1-60327-197-4
87 978-1-60327-198-1
88 schema:name Characterization of Nanoparticles Intended for Drug Delivery
89 rdf:type schema:Book
90 N96b1612ad41c414ca2a59b94bfd57eac schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
91 schema:name Humans
92 rdf:type schema:DefinedTerm
93 Nc99c426cc50d4a1b973e0751033b6489 schema:name pubmed_id
94 schema:value 21116949
95 rdf:type schema:PropertyValue
96 Ncdb343dbe4fb41b891f6651377e159fd schema:name dimensions_id
97 schema:value pub.1034612500
98 rdf:type schema:PropertyValue
99 Nd7ca21cc8b9d48889ba9c3b5e4de0570 schema:name doi
100 schema:value 10.1007/978-1-60327-198-1_1
101 rdf:type schema:PropertyValue
102 Neea06bb06c8540f28524d61606bde706 schema:location Totowa, NJ
103 schema:name Humana Press
104 rdf:type schema:Organisation
105 Nf73d3c9d75574d9c953f9ba9f16b8d6d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
106 schema:name Drug Delivery Systems
107 rdf:type schema:DefinedTerm
108 anzsrc-for:03 schema:inDefinedTermSet anzsrc-for:
109 schema:name Chemical Sciences
110 rdf:type schema:DefinedTerm
111 anzsrc-for:0306 schema:inDefinedTermSet anzsrc-for:
112 schema:name Physical Chemistry (incl. Structural)
113 rdf:type schema:DefinedTerm
114 sg:grant.5246872 http://pending.schema.org/fundedItem sg:pub.10.1007/978-1-60327-198-1_1
115 rdf:type schema:MonetaryGrant
116 sg:person.01066372523.29 schema:affiliation N5160a2b2159747bcb1f2d51deebb607d
117 schema:familyName McNeil
118 schema:givenName Scott E.
119 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01066372523.29
120 rdf:type schema:Person
121 sg:pub.10.1007/0-306-47932-x_2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047588034
122 https://doi.org/10.1007/0-306-47932-x_2
123 rdf:type schema:CreativeWork
124 sg:pub.10.1038/nrd1033 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000722784
125 https://doi.org/10.1038/nrd1033
126 rdf:type schema:CreativeWork
127 https://doi.org/10.1016/j.addr.2005.09.014 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003846396
128 rdf:type schema:CreativeWork
129 https://doi.org/10.1016/s0168-3659(99)00248-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044151490
130 rdf:type schema:CreativeWork
131 https://doi.org/10.1016/s1359-6446(03)02903-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038206642
132 rdf:type schema:CreativeWork
133 https://doi.org/10.1073/pnas.93.24.14164 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001856115
134 rdf:type schema:CreativeWork
135 https://doi.org/10.1080/10717540490433895 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038778560
136 rdf:type schema:CreativeWork
137 https://doi.org/10.1093/annonc/mdl104 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035014334
138 rdf:type schema:CreativeWork
139 https://doi.org/10.1158/1078-0432.ccr-05-1634 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007182456
140 rdf:type schema:CreativeWork
141 https://doi.org/10.1517/14712598.4.8.1213 schema:sameAs https://app.dimensions.ai/details/publication/pub.1067589512
142 rdf:type schema:CreativeWork
 




Preview window. Press ESC to close (or click here)


...